Skip to product information
1 of 2

Janssen Pharmaceuticals

Invega Sustenna Injection 100mg

Invega Sustenna Injection 100mg

Regular price $385.87 AUD
Regular price $0.00 AUD Sale price $385.87 AUD
Sale Sold out
Shipping calculated at checkout.

Invega Sustenna Injection 100 Mg

Invega Sustenna is a long-acting injectable antipsychotic medication used for the treatment of schizophrenia and schizoaffective disorder. It contains the active ingredient paliperidone, which alters the activity of certain natural substances in the brain to help manage symptoms.

Key Features
  • Long-acting formulation for monthly administration
  • Effective in managing symptoms of schizophrenia
  • Can be used alone or with other medications for schizoaffective disorder
Technical Specifications
  • Active Ingredient Paliperidone 100 mg
  • Administration Intramuscular injection
  • Frequency Monthly
Application or Use Case

Ideal for patients requiring long-term management of schizophrenia or schizoaffective disorder.

Typical User/Industry Profile

Healthcare professionals treating patients with schizophrenia or schizoaffective disorder.

About the Brand

Invega Sustenna is developed by Janssen Pharmaceuticals, a leader in mental health treatments, known for pioneering innovative solutions in the field of antipsychotic medications.

View full details